ZWITTERION SURFACE MODIFICATIONS FOR CONTINUOUS SENSORS

• US 20150080691A1
• Filed: 11/17/2014
• Published: 03/19/2015
• Est. Priority Date: 09/28/2012
• Status: Active Grant

• Current Assignee: DexCom Incorporated
• Original Assignee: DexCom Incorporated
• Inventors: Boock, Robert J., Dring, Chris W.
• Granted Patent: US 10,045,723 B2
• Time in Patent Office: Days
• US Class Current: 600/347
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/1486 using enzyme electrodes, e.g. with immobilised oxidase
• CPC Class Codes: A61B 5/14865 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors

Abstract

Devices are provided for measurement of an analyte concentration, e.g., glucose in a host. The device can include a sensor configured to generate a signal associated with a concentration of an analyte; and a sensing membrane located over the sensor. The sensing membrane comprises a diffusion resistance domain configured to control a flux of the analyte therethrough. The diffusion resistance domain comprises one or more zwitterionic compounds and a base polymer comprising both hydrophilic and hydrophobic regions.

Claims

1-10. -10. (canceled)

11. A device for measurement of a glucose concentration, the device comprising:

a sensor configured to generate a signal indicative of a glucose concentration; and

a sensing membrane located over the sensor, wherein the sensing membrane comprises an outermost domain, wherein the outermost domain comprises a copolymer, wherein the copolymer comprises at least one betaine compound or a derivative thereof, and wherein the copolymer comprises both hydrophilic and hydrophobic regions.

12. The device of claim 11, wherein an amount of the at least one betaine compound or the derivative thereof in the outermost domain is from about 1% wt. to about 50% wt. of the outermost domain.

13. The device of claim 11, wherein an amount of the at least one at least one betaine compound or the derivative thereof in the outermost domain is from about 10% wt to about 40% wt. of the outermost domain.

14. The device of claim 11, wherein the at least one betaine compound or the derivative thereof comprise at least one compound selected from the group consisting of a carboxyl betaine compound, a sulfo betaine compound, a phosphor betaine compound, and derivatives thereof.

15. The device of claim 11, wherein the at least one betaine compound or the derivative thereof comprises at least one compound selected from the group consisting of cocamidopropyl betaine, oleamidopropyl betaine, octyl sulfobetaine, caprylyl sulfobetaine, lauryl sulfobetaine, myristyl sulfobetaine, palmityl sulfobetaine, stearyl sulfobetaine, betaine (trimethylglycine), octyl betaine, phosphatidylcholine, glycine betaine, poly(carboxybetaine), poly(sulfobetaine), and derivatives thereof.

16. The device of claim 11, wherein the at least one betaine compound or the derivative thereof comprises at least one compound selected from the group consisting of poly(carboxybetaine), poly(sulfobetaine), and derivatives thereof.

17. The device of claim 11, wherein the sensing membrane further comprises an enzyme domain comprising an enzyme selected from the group consisting of glucose oxidase, glucose dehydrogenase, galactose oxidase, cholesterol oxidase, amino acid oxidase, alcohol oxidase, lactate oxidase, and uricase.

18. The device of claim 17, wherein the enzyme is glucose oxidase.

19. The device of claim 11, wherein the membrane has a thickness from about 0.1 microns to about 1 micron.

20. The device of claim 11, wherein the membrane has a thickness from about 0.1 microns to about 0.5 micron.

21. The device of claim 11, wherein the copolymer is a polyurethane copolymer.

22. The device of claim 11, wherein the polyurethane copolymer is a polyurethane urea copolymer.

23. The device of claim 11, wherein the sensor comprises an electrode.

24. The device of claim 11, wherein the device is configured for continuous measurement of glucose concentration.